Your session is about to expire
← Back to Search
LifeSkills Mobile for HIV Prevention (LifeSkills Trial)
LifeSkills Trial Summary
This trial will test if the LifeSkills app can help reduce HIV incidence among young transgender women in the US.
LifeSkills Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLifeSkills Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LifeSkills Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 16 and 29 years old.I tested positive for HIV using a home test kit.I identify as a woman or along the feminine spectrum and was assigned male at birth.
- Group 1: Standard of Care
- Group 2: LifeSkills Mobile
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals have been enrolled in this clinical trial thus far?
"Affirmative. According to the clinicaltrials.gov registry, this medical study is actively recruiting participants, having been posted on December 6th 2021 and last updated July 21st 2022. The trial requires 5100 patients from a single location for completion."
Is this research available for patient participation at present?
"According to clinicaltrials.gov, this investigation is currently looking for participants and was initially listed on December 6th 2021 with the latest update occurring on July 21st 2022."
Are senior citizens in the 65+ age range able to participate in this medical trial?
"This medical study requires that participants are aged 16 to 29. Additionally, there are 5 studies specifically for people younger than 18 and 16 trials catered towards those over 65."
Share this study with friends
Copy Link
Messenger